Nuclear	B-Cellular_component
translocation	O
of	O
a	O
clusterin	O
isoform	O
is	O
associated	O
with	O
induction	O
of	O
anoikis	O
in	O
SV40	O
-	O
immortalized	O
human	O
prostate	B-Cell
epithelial	I-Cell
cells	I-Cell
.	O

Clusterin	O
gene	O
expression	O
is	O
potently	O
induced	O
in	O
experimental	O
models	O
in	O
which	O
apoptosis	O
is	O
activated	O
,	O
such	O
as	O
rat	O
prostate	B-Organ
involution	O
following	O
castration	O
.	O

Nevertheless	O
,	O
its	O
precise	O
physiological	O
role	O
has	O
not	O
yet	O
been	O
established	O
,	O
and	O
both	O
anti	O
-	O
apoptotic	O
and	O
pro	O
-	O
apoptotic	O
functions	O
have	O
been	O
suggested	O
for	O
this	O
gene	O
.	O

Clusterin	O
expression	O
level	O
depends	O
on	O
cell	B-Cell
proliferation	O
state	O
,	O
and	O
we	O
recently	O
showed	O
that	O
its	O
over	O
-	O
expression	O
inhibited	O
cell	B-Cell
cycle	O
progression	O
of	O
SV40	O
-	O
immortalized	O
human	O
prostate	B-Cell
epithelial	I-Cell
cells	I-Cell
PNT2	I-Cell
and	O
PNT1a	B-Cell
.	O

Here	O
we	O
studied	O
clusterin	O
expression	O
in	O
PNT1a	B-Cell
cells	I-Cell
subjected	O
to	O
serum	B-Organism_substance
-	O
starvation	O
with	O
the	O
aim	O
of	O
defining	O
clusterin	O
early	O
molecular	O
changes	O
following	O
apoptosis	O
induction	O
.	O

Under	O
serum	B-Organism_substance
-	O
starvation	O
conditions	O
,	O
decreased	O
growth	O
rate	O
,	O
slow	O
rounding	O
-	O
up	O
of	O
cells	B-Cell
,	O
cell	B-Cell
detachment	O
,	O
and	O
formation	O
of	O
apoptotic	B-Cellular_component
bodies	I-Cellular_component
indicative	O
of	O
anoikis	O
(	O
detachment	O
-	O
induced	O
apoptosis	O
)	O
were	O
preceded	O
by	O
significant	O
downregulation	O
of	O
70	O
kDa	O
clusterin	O
precursor	O
and	O
upregulation	O
of	O
45	O
-	O
40	O
kDa	O
isoforms	O
.	O

On	O
the	O
8th	O
day	O
of	O
serum	B-Organism_substance
-	O
free	O
culturing	O
,	O
only	O
the	O
higher	O
molecular	O
weight	O
protein	O
-	O
band	O
of	O
about	O
45	O
kDa	O
was	O
clearly	O
induced	O
and	O
accumulated	O
in	O
detached	O
cells	B-Cell
and	O
apoptotic	B-Cellular_component
bodies	I-Cellular_component
in	O
which	O
PARP	O
was	O
activated	O
.	O

Anoikis	O
was	O
preceded	O
by	O
induction	O
and	O
transloction	O
of	O
a	O
45	O
-	O
kDa	O
clusterin	O
isoform	O
to	O
the	O
nucleus	B-Cellular_component
.	O

Thus	O
,	O
nuclear	B-Cellular_component
targeting	O
of	O
a	O
specific	O
45	O
-	O
kDa	O
isoform	O
of	O
clusterin	O
appeared	O
to	O
be	O
an	O
early	O
and	O
specific	O
molecular	O
signal	O
triggering	O
anoikis	O
-	O
death	O
.	O

Considering	O
also	O
that	O
clusterin	O
is	O
downregulated	O
during	O
prostate	B-Cancer
cancer	I-Cancer
onset	O
and	O
progression	O
,	O
and	O
that	O
its	O
upregulation	O
has	O
inhibited	O
DNA	O
synthesis	O
and	O
cell	B-Cell
cycle	O
progression	O
of	O
immortalized	O
human	O
prostate	B-Cell
epithelial	I-Cell
cells	I-Cell
,	O
we	O
suggest	O
that	O
clusterin	O
might	O
be	O
a	O
new	O
anti	O
-	O
oncogene	O
in	O
the	O
prostate	B-Organ
.	O

